Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
REGEN Capital is an equity-based investment firm based in downtown Toronto, focused on early-stage companies across North America. The firm specializes in frontier technologies, particularly in the healthcare sector, and has a check size range of $50,000 to $250,000. Their portfolio includes notable achievements in regenerative medicine and multiple patents in the field.
REGEN Capital invests in pre-seed to early-stage companies, typically leading rounds with check sizes between $50,000 and $250,000. The firm targets sectors such as biotechnology, financial technology, artificial intelligence, quantum computing, healthcare, and real estate. They emphasize close partnerships with portfolio companies, offering operational support and strategic guidance.
Notable companies in REGEN Capital's portfolio include Canadian Centre for Regenerative Therapy (CCRT), the first private cell therapy center in Canada, and Freyja Therapeutics, which focuses on umbilical cord stem cells for treating inflammatory diseases.
Submit your pitch through their website's contact form for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.